Rock Health News

 

Funding 4/2/18

Q1 2018: Funding keeps climbing as digital health startups double down on validation

On the heels of the biggest year in venture funding, the digital health space is starting off 2018 with a bang: record Q1 funding of $1.62B, three $100M+ mega-deals, and a massive exit. Compared to last year, the commotion from policy debates has largely settled and a path to regulatory clarity has emerged. On our end, we’ve launched a couple of new sections within our funding post—check out our deep investor analysis as well as an update on the sometimes elusive, always critical quest of every digital health company: validation.

Featured 3/1/18

The real-world effects of digital health: Announcing the Impact Project

After seven years, we’ve seen $23B invested into thousands of digital health companies. But we wanted to know: what has been the real-world impact of digital health? We were moved to learn just how many lives had been significantly changed by a new wave of technology. We aim to shift the digital health dialogue from one focused on the degree of investment and future expectations to one about digital health’s effect on patients and healthcare outcomes. In that spirit, this ongoing project brings you stories of people living far outside Silicon Valley and the companies shifting the healthcare status quo who have made an impact on their lives.

Featured 2/20/18

Demystifying AI and Machine Learning in Healthcare

AI in healthcare feels inevitable: Optimists predict that artificial intelligence and machine learning (AI/ML) will diagnose disease better and earlier, treat illness more precisely, and engage patients more efficiently than today’s healthcare system does. On top of this, AI/ML is expected to streamline business operations and restore sanity (and humanity) to the clinician experience. To separate hype from reality, read our 50-page white paper, Demystifying AI and Machine Learning in Healthcare.

Featured 1/18/18

FDA compliance made easy: Welcome, Enzyme!

Even small med device, drug, or digital health companies can shell out hundreds of thousands of dollars annually in consulting fees on labor-intensive, slow, paper-based processes—with larger companies spending millions. These companies are tackling some of healthcare’s biggest problems, and we believe regulatory compliance workflow shouldn’t be an expensive bottleneck. That’s why we’re thrilled to announce our latest investment in Enzyme, a company building software to help large and small enterprises alike streamline workflow, making regulatory compliance a seamless part of the development process.

Funding 1/8/18

2017 Year End Funding Report: The end of the beginning of digital health

2017 was a record-smashing year for digital health, with venture funding approaching $6B and the most mega deals ($100M+) to date. It’s clear that the early game has concluded and digital health is entering the “middle innings” as an investment sector.

×